Revenue is immediate... to my knowledge no discussion around consolidation has or is taking place - an irrelevant and unnecessary mgmt distraction atm!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%